BeiGene
BGNE
#967
Rank
ยฃ15.67 B
Marketcap
ยฃ143.30
Share price
0.49%
Change (1 day)
14.41%
Change (1 year)
BeiGene is a Chinese pharmaceutical company engaged in the R&D, and commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Market capitalization of BeiGene (BGNE)

Market cap: ยฃ15.67 Billion

As of March 2025 BeiGene has a market cap of ยฃ15.67 Billion. This makes BeiGene the world's 967th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of BeiGene from 2016 to 2025

End of year Market Cap

Year Marketcap Change
2025ยฃ15.67 B-0.57%
2024ยฃ15.76 B1.36%
2023ยฃ15.55 B-19.79%
2022ยฃ19.39 B-4.77%
2021ยฃ20.36 B15.51%
2020ยฃ17.63 B124.7%
2019ยฃ7.84 B19.49%
2018ยฃ6.56 B99.4%
2017ยฃ3.29 B237.3%
2016ยฃ0.97 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
ยฃ16.21 M-99.90%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.98 B-93.72%๐Ÿ‡บ๐Ÿ‡ธ USA